Global Circulating Tumor Cells (CTC) Market Share

Statistics for the 2023 & 2024 Global Circulating Tumor Cells (CTC) market share, created by Mordor Intelligence™ Industry Reports. Global Circulating Tumor Cells (CTC) share report includes a market forecast to 2029 and historical overview. Get a sample of this industry share analysis as a free report PDF download.

Home Market Analysis Healthcare Research Biotechnology Research Biotechnology R&D Research Life Science Research Technologies Research Cytology Research Circulating Tumor Cells Industry Market Share

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:

Market Share of Global Circulating Tumor Cells (CTC) Industry

The market studied is a moderately consolidated market, owing to the presence of small and large market players. Some market players are Advanced Cell Diagnostics Inc., Aviva Biosciences, Biocept Inc., Creatv Micro Tech, Inc., LungLife AI Inc., Menarini Silicon Biosystems, and Miltenyi Biotec, Precision For Medicine (Formerly ApoCell), and Qiagen NV.

Circulating Tumor Cells (CTC) Market Leaders

  1. Menarini Silicon Biosystems

  2. Miltenyi Biotec

  3. Precision For Medicine (Formerly ApoCell)

  4. Qiagen NV

  5. Biocept Inc

*Disclaimer: Major Players sorted in no particular order

Advanced Cell Diagnostics Inc., Aviva Biosciences, Biocept Inc., Creatv Micro Tech, Inc., LungLife AI Inc., Menarini Silicon Biosystems, Miltenyi Biotec, Precision For Medicine (Formerly ApoCell), and Qiagen NV.

CTC Market Report Snapshots

CTC Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)